XTalks

JULY 28, 2021

Merck has scored US Food and Drug Administration (FDA) approval for its next-generation pneumonia vaccine Vaxneuvance that covers 15 different strains of the pneumococcal bacteria that causes the infection. Both next-gen shots offer enhanced protection against bacteria that can cause pneumonia, blood infections and meningitis.

FDA Approval 70

FDA Approval Vaccination Vaccine Immune Response 70

XTalks

JULY 25, 2023

Anthrax is a rare, yet severe disease caused by the bacterium B. The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. One such vaccine is BioThrax which was also developed by Emergent BioSolutions and gained FDA clearance back in 1970.

FDA Approval 95

FDA Approval Vaccination Vaccine Antibody 95

Pharmaceutical Technology

MAY 18, 2023

An investigational orally delivered biologic drug, LMN-201 is a cocktail of four therapeutic proteins that act synergistically to neutralise the C difficile bacterium and the toxin. The company has already received FDA approval for a Phase II/III trial, which will begin to enrol 375 participants at sites across the US during 2023.

Bacterium 130

Bacterium Bacteria FDA Approval Trials 130

pharmaphorum

JULY 2, 2021

Under the terms of the new deal, Nestle’s Health Sciences unit will pay Seres another $125 million if the FDA approves the drug – called SER-109 – and is also line for up to $225 million in commercial milestones tied to sales targets. Nestle and Seres have been working together on the microbiome project since 2016, focusing on C.

Bacterium 69

Bacterium Drugs Bacteria FDA Approval 69

Pharmaceutical Technology

OCTOBER 28, 2022

The company says that these four serotypes represent roughly 10–15% of bacteria causing pneumococcal disease in adults. While the first pneumococcal polysaccharide vaccine was approved in the US in 1977, the first conjugate shot Prevnar was greenlighted only in 2000.

Vaccination 162

Vaccination Vaccine Marketing Bacteria 162

XTalks

AUGUST 2, 2023

Paxlovid was first authorized under the FDA Emergency Use Authorization in December 2021 ; however, it has received FDA approval on May 25, 2023. pneumoniae serotypes) replaced the company’s first pneumococcal conjugate vaccine Prevnar (PCV7, approved by the FDA in February 2000) in a February 2010 FDA approval.

Sales 96

Sales Manufacturing FDA Approval Life Science 96

XTalks

DECEMBER 24, 2020

Several saliva-based tests also received FDA approvals and authorizations, making sample collection easier and less invasive compared with traditional nasopharyngeal swabbing. Charpentier demonstrated that the CRISPR/Cas system functions to provide adaptive immunity against foreign DNA in prokaryotes such as bacteria and archaea.

Life Science 110

Life Science Vaccination Vaccine Gene 110